Earum Pharmaceuticals Ltd.

View in App
1.03 +0.04 ▲4.0%

11 December 2023, 04:01:00 PM
Volume: 2,299,078

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.earumpharma.com
Market Cap 25.45 Cr.
Enterprise Value(EV) 27.97 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.02 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 53.14 Trailing Twelve Months Ending 2023-09
Industry PE 38.37 Trailing Twelve Months Ending 2023-09
Book Value / Share 2.21 Trailing Twelve Months Ending 2023-09
Price to Book Value 0.47 Calculated using Price: 1.03
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 24.71 Cr. 247,111,618 Shares
FaceValue 2
About Earum Pharmaceuticals Ltd.
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Earum Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Earum Pharmaceuticals Ltd. Performance

View details >>
1 Day
+4.04%
1 Week
+1.98%
1 Month
-7.21%
3 Month
+1.98%
6 Month
-50.48%
1 Year
-54.02%
2 Year
-90.41%
5 Year
10 Year

Earum Pharmaceuticals Ltd. Fundamental Ratios

View details >>
8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.15 11.05 30.94 32.17 17.83 0.61 14.24 11.18
Return on Capital Employed (%) 17.10 21.97 24.94 23.99 17.40 4.23 12.34 11.66
Return on Assets (%) 1.11 1.61 5.98 7.77 6.11 0.28 7.85 6.91

Earum Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 2 5 6 14 15 17 19 55
Non Curr. Liab. 0 1 2 3 1 2 0 0 0
Curr. Liab. 7 9 13 15 20 11 12 10 6
Minority Int.
Equity & Liab. 9 11 20 23 36 28 29 29 60
Non Curr. Assets 0 0 0 0 4 1 1 0 0
Curr. Assets 9 11 19 23 32 27 28 28 60
Misc. Exp. not W/O
Total Assets 9 11 20 23 36 28 29 29 60

Earum Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 19 23 35 51 55 41 21 14 5
Other Income 0 0 0 0 2 9 8 2 2
Total Income 19 24 36 51 57 50 29 16 7
Total Expenditure -18 -23 -34 -47 -54 -49 -25 -13 -5
PBIDT 1 1 2 3 4 1 3 3 2
Interest 0 -1 -1 -1 -1 -1 0 0 -1
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 -1 0 -1 -1 -1
Exceptional Items
PAT 0 0 1 2 2 0 2 2 0
Adjusted EPS 0 0 0 0 0 0 0 0

Earum Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -7 0 -3 -7 3 0
Cash Fr. Inv. 0 0 0 0 -3 3 0
Cash Fr. Finan. 1 0 7 1 7 3 -3 0
Net Change 0 0 0 0 0 -1 0 0
Cash & Cash Eqvt 0 0 0 0 0 -1 0 0

Earum Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 70.04 70.04 50.21 37.57 0.00 0.00 0.00 0.00 0.00
Public 29.96 29.96 49.79 62.43 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Earum Pharmaceuticals Ltd. Announcements

View details >>
Sat, 09 Dec 2023
Submission Of Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2023 Along With Limited Review Report
Submission of Unaudited Financial Results for the Quarter and Half year ended on 30th September 2023 along with Limited review Report
Sat, 09 Dec 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 9Th December 2023 As Per Regulation 30 Of SEBI (LODR) Regulations 2015
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Saturday 9th December 2023 at the Registered Office of the Company which commenced at 3:00 P. M. and concluded at 4:30 P. M. inter-alia has consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended on 30th September 2023 along with Limited Review Report.
Fri, 13 Oct 2023
Reg. 34 (1) Annual Report.
Kindly find the attached Annual Report of the Company.

Earum Pharmaceuticals Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low

Earum Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,829.45 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,460.15 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,752.32 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,347.58 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.18 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.34 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.73 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.98 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.69 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Earum Pharmaceuticals Ltd. FAQ's

What is Earum Pharmaceutical share price?
Can I buy Earum Pharmaceutical shares now?
What is the Market Cap of Earum Pharmaceutical?
What are the key metrics to analyse Earum Pharmaceutical?
What is the 52 Week High and Low of Earum Pharmaceutical?
What is the trend of Earum Pharmaceutical share price?